1. The Role of N-Methyl-D-Aspartate Receptor Neurotransmission and Precision Medicine in Behavioral and Psychological Symptoms of Dementia
   Chieh-Hsin Lin et al, 2019, Front. Pharmacol. CrossRef
2. Pharmacologic Approaches for the Management of Apathy in Neurodegenerative Disorders
   Anamaria Bogdan et al, 2020, Front. Pharmacol. CrossRef
3. Benefits and Harms of Prescription Drugs and Supplements for Treatment of Clinical Alzheimer-Type Dementia
   Howard A. Fink et al, 2020, Annals of Internal Medicine CrossRef
4. Some Candidate Drugs for Pharmacotherapy of Alzheimer’s Disease
   Barbara Miziak et al, 2021, Pharmaceuticals CrossRef
5. Personalizing the Care and Treatment of Alzheimer’s Disease: An Overview
   Dubravka Svob Strac et al, 2021, PGPM CrossRef
6. QTc Interval Prolongation with Therapies Used to Treat Patients with Parkinson’s Disease Psychosis: A Narrative Review
   Yasar Torres-Yaghi et al, 2021, NDT CrossRef
7. Tailoring the therapeutic interventions for behavioral and psychological symptoms of dementia
   Barbara Vuic et al, 2022, Expert Review of Neurotherapeutics CrossRef
8. Comparative efficacy and safety of antidepressant therapy for the agitation of dementia: A systematic review and network meta-analysis
   Kaili Chen et al, 2023, Front. Aging Neurosci. CrossRef
9. Detection and analysis of signals of adverse events of memantine based on the US food and drug administration adverse event reporting system
   Weichui Zhang et al, 2024, Expert Opinion on Drug Safety CrossRef
10. Efficacy of selective serotonin reuptake inhibitors-related antidepressants in Alzheimer’s disease: a meta-analysis
    Haiyan Wang et al, 2024, Eur J Med Res CrossRef